POC testing: the hospital bedside critical care market
This article was originally published in Clinica
Hospital-based point-of-care (POC) testing is the smallest of the three segments that make up the total POC diagnostics market (the others being physician’s office testing and home-based or self-testing), accounting for about 13% in 2008. The sector is fairly mature, although certain high-growth applications remain. The growth rate for hospital-based POC testing products remains above that for the general diagnostics market, due in part to certain subsegments that are exhibiting rapid growth, such as critical care testing and POC coagulation testing. New POC tests under development or recently introduced into the hospital setting, including those for sepsis and stroke, are expected to drive continued growth in the market in the longer term.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.